Table 3.
Relationship Between Expression of lncRNA BCAR4 and Clinical Pathology
| Pathological Feature | Sample No. | lncRNA BCAR4 [n (%)] | p Value | |
|---|---|---|---|---|
| Low Expression | High Expression | |||
| Sex | 0.4887 | |||
| Male | 35 | 6 (40.3%) | 29 (59.7%) | |
| Female | 29 | 7 (36.4%) | 22 (63.6%) | |
| Age (years) | 0.2256 | |||
| <60 | 24 | 8 (62.5%) | 16 (37.5%) | |
| ≥60 | 40 | 5 (65.5%) | 35 (37.5%) | |
| Cancer type | 0.8856 | |||
| SCC | 30 | 6 (61.1%) | 24 (38.9%) | |
| AC | 34 | 7 (63.1%) | 37 (36.9%) | |
| Smoking history | 0.9003 | |||
| Positive | 40 | 9 (63.4%) | 31 (36.6%) | |
| Negative | 24 | 4 (60.9%) | 20 (39.1%) | |
| Lymph metastasis | 0.0312* | |||
| Positive | 41 | 5 (63.4%) | 36 (36.6%) | |
| Negative | 23 | 8 (60.9%) | 15 (39.1%) | |
SCC, squamous cell carcinoma; AC, adenomatous carcinoma.
*
p < 0.05, chi-square test.